Your session is about to expire
← Back to Search
Micro-Ultrasound for Prostate Cancer Detection
Study Summary
This trial is testing whether micro-ultrasound can more accurately detect and characterize prostate cancer tumors than the current standard, multiparametric magnetic resonance imaging. If micro-ultrasound is shown to be more accurate, it may reduce the need for radical prostatectomy, which is an invasive and expensive procedure.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 2 trial • 86 Patients • NCT03279250Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had radiation or a specific treatment for prostate cancer.I am scheduled for a surgery to remove my prostate.I had a special MRI for prostate cancer within the last year.My prostate cancer is confirmed by biopsy and is aggressive.I had a prostate biopsy less than 4 weeks ago.My prostate size is 6 cm or smaller.
- Group 1: Diagnostic (TRUS)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the enrollment phase of this trial still open?
"The information available on clinicaltrials.gov indicates that this particular research trial is not presently recruiting participants, even though it was submitted to the site back in October 2020 and last amended just over a year ago. Despite its inactive status, there are 1,322 other trials with open calls for patients at present."
Share this study with friends
Copy Link
Messenger